Antileukemic activity of eicosapentaenoic acid (EPA)–derived cyclopentenone prostaglandins. Left panel shows a liquid chromatography-UV trace of EPA-derived metabolites endogenously produced by macrophages. Right panel demonstrates the selective antileukemic effect of Δ¹²-PGJ₃ on BCR-ABL–transformed leukemic stem cells.